A German pharmaceutical company required a well-coordinated laboratory move to a newly built space to accommodate growing tasks and operations. The challenge was to ensure no interruptions to testing workflows, maintain full GxP compliance, and meet strict timelines without impacting lot release schedules. Zamann Pharma Support was engaged to plan and manage this transition, providing detailed organization, communication, and risk management.
Our team supports the planning, execution, and maintenance of qualification and validation activities, including IQ, OQ, and PQ, to keep GMP-regulated systems compliant and under control.
Teams maintain continuity by mapping every analytical workflow before the move and classifying activities by criticality. High-priority testing streams receive backup capacity planning, either through parallel instruments or pre-approved external testing routes. This ensures lot release timelines stay protected even when equipment is temporarily offline during relocation phases.
The most effective approach starts with a risk-based assessment that identifies critical instruments, validated methods, and data integrity points. Teams then document mitigation strategies for each risk, including equipment qualification status checks and controlled transport procedures. As a result, compliance remains traceable across every step of the move and supports inspection readiness at any stage.
